What can the Neuromonics devices offer patients in need of treatment or management of disturbing tinnitus? The unique aspects of the Neuromonics stimulus and mechanisms by which it provides a clinically effective sound therapy are discussed. Also reviewed will be the characteristics of the Neuromonics Oasis and Sanctuary devices along with a description of the appropriate tinnitus patient populations for each device.
Course created on November 14, 2013
Learning Outcomes
- After completion of this course learners will be to determine appropriate patient candidates for the Neuromonics Sanctuary device.
- After completion of this course learners will be to determine appropriate patient candidates for the Neuromonics Oasis device.
- After completion of this course learners will be able to describe the therapeutic, clinically effective elements of the Neuromonics Phase One sound therapy stimulus.
- After completion of this course learner will be able to identify characteristics of the Neuromonics Sanctuary and Oasis devices.
- After completion of this course learner will be able to identify device delivery characteristics of the Neuromonics Sanctuary and Oasis devices
- After completion of this course learners will be able to describe why the Neuromonics Phase One sound therapy stimulus is effective for patient with disturbing tinnitus.
Agenda
0-5 Minutes | Introduction |
5-15 Minutes | Tinnitus Pathogenesis and Neuromonics Mechanism of Action |
15-25 Minutes | Clinically effective elements of music and the Neuromonics Phase One Stimulus for the treatment/management of tinnitus disturbance |
25-40 Minutes | Candidacy Considerations for the Oasis and Sanctuary devices |
40-55 Minutes | Characteristics of Oasis and Sanctuary devices and device delivery |
55-60 Minutes | QA |
Reviews
21 ReviewsPresented By
Curtis Amann
MBA
Vice President of Sales and Marketing
Curtis Amann B.A. (Tulane University), M.B.A. (Tulane University) Curtis is the Vice President of Sales and Marketing for Neuromonics Inc. During his tenure with Neuromonics he has been responsible for all Neuromonics Marketing initiatives, Customer Service, establishing new Neuromonics Treatment Providers, as well as, supporting existing Neuromonics Providers throughout the US.
More
Casie Keaton
AuD CCC-A
Clinical Sales Manager
Casie has been with Neuromonics since 2008 training audiologists in tinnitus and how to be effective in treating disturbing tinnitus. She has extensive clinical experience in helping patients improve their quality of life and be successful in overcoming their tinnitus with the Neuromonics therapy. Casie has completed research in the areas of psychoacoustics, pitch memory and auditory memory.
More
Casie Keaton: Financial: Casie Keaton is employed by Neuronomics USA. Non-financial: Casie Keaton has no non-financial relationships to disclose.
Sponsor Disclosure: This Course is presented by Neuromonics in partnership with AudiologyOnline.
Content Disclosure: This learning event focuses on Neuromonics products and services and will not include info on other products or services.
Course participation information
To ensure you are ready to participate, please complete our short Test Drive to prepare your computer to view the course.
Full attendance is required, and the times you log in and out will be recorded and documented. If you log in to a live webinar late or if you log out early, you may not be able to earn CEU.
Passing an online exam and completing a course evaluation will be required to earn continuing education credit.
Live Webinars allow presenter and participant interaction. The exam and course evaluation for these courses must be completed within 7 days of the event.
On-demand courses include texts, video and audio recordings of live webinars, and multimedia formats. The exam and course evaluation for on-demand courses must be completed within 30 days of course registration.
To participate in the course, complete the exam and course evaluation, and earn continuing education credit, you must be a AudiologyOnline member. Participants must complete the entire course; partial credit is not allowed.
AudiologyOnline is committed to ensuring accessibility to the widest possible audience. We are continually improving the user experience for everyone. If you have questions, requests, or would like to report an accessibility-related issue, please email accessibility@continued.com. We will review your request and respond in a timely manner.
Visit our Contact us page or give us a call if you have questions.